Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Neoplasms × abarelix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasms 1

Interventions

E 7107 2 Carboplatin 2 palbociclib 1 gedatolisib 1 eniluracil 1 dabrafenib 1 abarelix 1 Topotecan 1 Therapeutics 1 Standard of Care 1 Radionuclide Imaging 1 Radiofrequency Ablation 1 Practice Guidelines as Topic 1 Positron-Emission Tomography 1 Passive Cutaneous Anaphylaxis 1 Paclitaxel 1 NUC-1031 1 Morphine 1 Methadone 1 Maltose 1 KB004 1 Infusions, Parenteral 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hydromorphone 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Flucytosine 1 Etoposide 1 Docetaxel 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00103623 2006-09-19

The Plenaxis® Experience Study

PRAECIS Pharmaceuticals Inc.

Phase 4 Suspended

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡